Amgen, Inc. (AMGN)
439.26
-8.02
(-1.79%)
USD |
NASDAQ |
Oct 23, 16:00
441.99
+2.73
(+0.62%)
After-Hours: 20:00
Amgen Market Cap : 237.46B for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 237.46B |
| October 22, 2026 | 241.80B |
| October 21, 2026 | 236.97B |
| October 20, 2026 | 237.29B |
| October 19, 2026 | 229.72B |
| October 16, 2026 | 233.80B |
| October 15, 2026 | 234.64B |
| October 14, 2026 | 230.36B |
| October 13, 2026 | 223.18B |
| October 12, 2026 | 225.74B |
| October 09, 2026 | 224.28B |
| October 08, 2026 | 220.26B |
| October 07, 2026 | 223.31B |
| October 06, 2026 | 217.65B |
| October 05, 2026 | 217.85B |
| October 02, 2026 | 217.88B |
| October 01, 2026 | 220.17B |
| September 30, 2026 | 227.87B |
| September 29, 2026 | 229.02B |
| September 28, 2026 | 226.04B |
| September 25, 2026 | 224.14B |
| September 24, 2026 | 219.51B |
| September 23, 2026 | 219.53B |
| September 22, 2026 | 221.78B |
| September 21, 2026 | 212.54B |
| Date | Value |
|---|---|
| September 18, 2026 | 208.48B |
| September 17, 2026 | 205.31B |
| September 16, 2026 | 203.45B |
| September 15, 2026 | 203.08B |
| September 14, 2026 | 206.24B |
| September 11, 2026 | 204.00B |
| September 10, 2026 | 206.76B |
| September 09, 2026 | 211.52B |
| September 08, 2026 | 212.55B |
| September 04, 2026 | 236.37B |
| September 03, 2026 | 240.09B |
| September 02, 2026 | 239.40B |
| September 01, 2026 | 236.85B |
| August 31, 2026 | 232.39B |
| August 28, 2026 | 233.77B |
| August 27, 2026 | 236.24B |
| August 26, 2026 | 238.05B |
| August 25, 2026 | 239.07B |
| August 24, 2026 | 239.94B |
| August 21, 2026 | 237.50B |
| August 20, 2026 | 234.47B |
| August 19, 2026 | 239.14B |
| August 18, 2026 | 229.91B |
| August 17, 2026 | 226.72B |
| August 14, 2026 | 224.46B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Gilead Sciences, Inc. | 193.65B |
| Regeneron Pharmaceuticals, Inc. | 83.24B |
| AbbVie, Inc. | 504.75B |
| Biogen, Inc. | 37.03B |
| Abbott Laboratories | 179.44B |
Market Cap Related Metrics
| PE Ratio | 27.29 |
| PS Ratio | 6.246 |
| PEG Ratio | 0.8607 |
| Price to Book Value | 20.32 |
| Price to Free Cash Flow | 23.45 |
| Price | 439.26 |
| Earnings Yield | 3.66% |
| PEGY Ratio | 0.8033 |
| Operating PE Ratio | 18.75 |
| Normalized PE Ratio | 24.90 |